Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Andersen

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|January 5, 1985
Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor valuesC Rose, S M Thorpe, K W Andersen, et al.
Cancer Research|August 1, 1986
Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancerE R DeSombre, S M Thorpe, C Rose, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 CH T Mouridsen, C Rose, M Overgaard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1994
Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative GroupN Kroman, A Højgaard, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-BP Dombernowsky, H Brincker, M Hansen, et al.
Breast Cancer Research and Treatment|January 1, 1986
Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisoneC Rose, C Kamby, H T Mouridsen, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Classical prognostic factors in node-negative breast cancer: the DBCG experienceH T Mouridsen, J Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary resultsM Blichert-Toft, H Brincker, J A Andersen, et al.
Danish Medical Bulletin|August 1, 1981
Organisation of the Danish adjuvant trials in breast cancerK W Andersen, H T Mouridsen, T Castberg, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|January 5, 1985
Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor valuesC Rose, S M Thorpe, K W Andersen, et al.
Cancer Research|August 1, 1986
Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancerE R DeSombre, S M Thorpe, C Rose, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 CH T Mouridsen, C Rose, M Overgaard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1994
Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative GroupN Kroman, A Højgaard, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-BP Dombernowsky, H Brincker, M Hansen, et al.
Breast Cancer Research and Treatment|January 1, 1986
Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisoneC Rose, C Kamby, H T Mouridsen, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Classical prognostic factors in node-negative breast cancer: the DBCG experienceH T Mouridsen, J Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary resultsM Blichert-Toft, H Brincker, J A Andersen, et al.
Danish Medical Bulletin|August 1, 1981
Organisation of the Danish adjuvant trials in breast cancerK W Andersen, H T Mouridsen, T Castberg, et al.
Pageof 6